News
Small Cap Stock news
-
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition
[ad_1] The award recognizes Avantor’s outstanding efforts to support the expansion of life-altering innovative cell and gene therapies to treat complex diseases.…
Read More » -
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
[ad_1] VANCOUVER and MINNEAPOLIS – (NewMediaWire) – March 31, 2023 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN)…
Read More » -
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results
[ad_1] – Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe…
Read More » -
ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
[ad_1] Fremont, CA – (NewMediaWire) – March 31, 2023 – ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in…
Read More » -
Museum Hits the Number Two Destination Spot for Burbank
[ad_1] (NewMediaWire) – April 01, 2023 – Burbank, CA – Despite being surrounded by the biggest movie studios in the…
Read More » -
Address Thinning Hair or Bald Spots with Regenerative Hair Loss Treatments at QC Kinetix (Colchester)
[ad_1] Colchester, VT – (NewMediaWire) – March 31, 2023 – via QC Kinetix —Hair loss has many causes, from stress…
Read More » -
NewMediaWire | QC Kinetix (Exton)
[ad_1] Exton, PA – (NewMediaWire) – March 31, 2023 – via QC Kinetix — Although painless, dealing with thinning hair…
Read More » -
QC Kinetix (Sylvania) Offers Regenerative Sports Medicine Solutions in Toledo, OH
[ad_1] Toledo, OH – (NewMediaWire) – March 31, 2023 – via QC Kinetix — Athletes search for a sports medicine…
Read More » -
Splash Beverage Group Reports 2022 Fourth Quarter and Full Year Financial Results
[ad_1] Fort Lauderdale, FL – (NewMediaWire) – March 31, 2023 – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the…
Read More » -
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today…
Read More »
